APO Research
Talk to an analyst

APO RESEARCH · REPORT

Microphysiological System

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Microphysiological System Market Analysis and Forecast 2026-2032

28 December 2025215 pages

Choose your research edition.

Industry ResearchMicrophysiological System Industry Research Report 2026144 pages · $2,950 USDIndustry Growth & TrendsGlobal Microphysiological System Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Microphysiological System Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Microphysiological System Market Outlook and Growth Opportunities 2026217 pages · $4,250 USDMarket Analysis & ForecastGlobal Microphysiological System Market Analysis and Forecast 2026-2032215 pages · $4,950 USD

Market perspective

The global Microphysiological System market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Microphysiological System is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Microphysiological System is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Microphysiological System is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Microphysiological System is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Microphysiological System include Emulate, Mimetas, TissUse, InSphero, Hesperos, CN Bio, TNO, 28bio and Beijing Daxiang Biotech, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Microphysiological System, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Microphysiological System, also provides the revenue of main regions and countries. Of the upcoming market potential for Microphysiological System, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Microphysiological System revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Microphysiological System market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Microphysiological System revenue, projected growth trends, production technology, application and end-user industry.

Microphysiological System Segment by Company

Emulate

Mimetas

TissUse

InSphero

Hesperos

CN Bio

TNO

28bio

Beijing Daxiang Biotech

Newcells Biotech

Nortis (Quris-Al)

Valo Health (TARA Biosystems)

Altis Biosystems

Draper Laboratory

Netri

Bi/ond

ImmuONE

AlveoliX

Cherry Biotech

Ananda Devices

Obatala Sciences

BiomimX

React4life

Aracari Bio

StemPharm

SynVivo

Microphysiological System Segment by Type

Human Organ and Tissue Models

Disease Models

Non-Human Species Models

Microphysiological System Segment by Application

Pharmaceutical & Biotechnology Companies

Academic & Research Institutes

Others

Microphysiological System Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Microphysiological System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Microphysiological System and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Microphysiological System.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Microphysiological System in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Microphysiological System company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Microphysiological System revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Microphysiological System Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Human Organ and Tissue Models Major Player Table 3. Disease Models Major Player Table 4. Non-Human Species Models Major Player Table 5. Global Microphysiological System Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Pharmaceutical & Biotechnology Companies Major Player Table 7. Academic & Research Institutes Major Player Table 8. Others Major Player Table 9. Microphysiological System Industry Trends Table 10. Microphysiological System Industry Drivers Table 11. Microphysiological System Industry Opportunities and Challenges Table 12. Microphysiological System Industry Restraints Table 13. Global Microphysiological System Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Microphysiological System Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Microphysiological System Market Share by Region (2021-2026) Table 16. Global Microphysiological System Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Microphysiological System Market Share by Region (2027-2032) Table 18. Global Microphysiological System Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Microphysiological System Revenue Market Share by Players (2021-2026) Table 20. Global Microphysiological System Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Microphysiological System Key Players Headquarters & Area Served Table 22. Global Microphysiological System Players, Product Type & Application Table 23. Global Microphysiological System Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Microphysiological System by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Microphysiological System Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Microphysiological System Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Microphysiological System Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Microphysiological System Revenue Market Share by Type (2021-2026) Table 30. Global Microphysiological System Revenue Market Share by Type (2027-2032) Table 31. Global Microphysiological System Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Microphysiological System Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Microphysiological System Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Microphysiological System Revenue Market Share by Application (2021-2026) Table 35. Global Microphysiological System Revenue Market Share by Application (2027-2032) Table 36. Emulate Company Information Table 37. Emulate Business Overview Table 38. Emulate Microphysiological System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Emulate Microphysiological System Product Portfolio Table 40. Emulate Recent Development Table 41. Mimetas Company Information Table 42. Mimetas Business Overview Table 43. Mimetas Microphysiological System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Mimetas Microphysiological System Product Portfolio Table 45. Mimetas Recent Development Table 46. TissUse Company Information Table 47. TissUse Business Overview Table 48. TissUse Microphysiological System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. TissUse Microphysiological System Product Portfolio Table 50. TissUse Recent Development Table 51. InSphero Company Information Table 52. InSphero Business Overview Table 53. InSphero Microphysiological System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. InSphero Microphysiological System Product Portfolio Table 55. InSphero Recent Development Table 56. Hesperos Company Information Table 57. Hesperos Business Overview Table 58. Hesperos Microphysiological System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Hesperos Microphysiological System Product Portfolio Table 60. Hesperos Recent Development Table 61. CN Bio Company Information Table 62. CN Bio Business Overview Table 63. CN Bio Microphysiological System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. CN Bio Microphysiological System Product Portfolio Table 65. CN Bio Recent Development Table 66. TNO Company Information Table 67. TNO Business Overview Table 68. TNO Microphysiological System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. TNO Microphysiological System Product Portfolio Table 70. TNO Recent Development Table 71. 28bio Company Information Table 72. 28bio Business Overview Table 73. 28bio Microphysiological System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. 28bio Microphysiological System Product Portfolio Table 75. 28bio Recent Development Table 76. Beijing Daxiang Biotech Company Information Table 77. Beijing Daxiang Biotech Business Overview Table 78. Beijing Daxiang Biotech Microphysiological System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Beijing Daxiang Biotech Microphysiological System Product Portfolio Table 80. Beijing Daxiang Biotech Recent Development Table 81. Newcells Biotech Company Information Table 82. Newcells Biotech Business Overview Table 83. Newcells Biotech Microphysiological System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Newcells Biotech Microphysiological System Product Portfolio Table 85. Newcells Biotech Recent Development Table 86. Nortis (Quris-Al) Company Information Table 87. Nortis (Quris-Al) Business Overview Table 88. Nortis (Quris-Al) Microphysiological System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Nortis (Quris-Al) Microphysiological System Product Portfolio Table 90. Nortis (Quris-Al) Recent Development Table 91. Valo Health (TARA Biosystems) Company Information Table 92. Valo Health (TARA Biosystems) Business Overview Table 93. Valo Health (TARA Biosystems) Microphysiological System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Valo Health (TARA Biosystems) Microphysiological System Product Portfolio Table 95. Valo Health (TARA Biosystems) Recent Development Table 96. Altis Biosystems Company Information Table 97. Altis Biosystems Business Overview Table 98. Altis Biosystems Microphysiological System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Altis Biosystems Microphysiological System Product Portfolio Table 100. Altis Biosystems Recent Development Table 101. Draper Laboratory Company Information Table 102. Draper Laboratory Business Overview Table 103. Draper Laboratory Microphysiological System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Draper Laboratory Microphysiological System Product Portfolio Table 105. Draper Laboratory Recent Development Table 106. Netri Company Information Table 107. Netri Business Overview Table 108. Netri Microphysiological System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Netri Microphysiological System Product Portfolio Table 110. Netri Recent Development Table 111. Bi/ond Company Information Table 112. Bi/ond Business Overview Table 113. Bi/ond Microphysiological System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Bi/ond Microphysiological System Product Portfolio Table 115. Bi/ond Recent Development Table 116. ImmuONE Company Information Table 117. ImmuONE Business Overview Table 118. ImmuONE Microphysiological System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. ImmuONE Microphysiological System Product Portfolio Table 120. ImmuONE Recent Development Table 121. AlveoliX Company Information Table 122. AlveoliX Business Overview Table 123. AlveoliX Microphysiological System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. AlveoliX Microphysiological System Product Portfolio Table 125. AlveoliX Recent Development Table 126. Cherry Biotech Company Information Table 127. Cherry Biotech Business Overview Table 128. Cherry Biotech Microphysiological System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Cherry Biotech Microphysiological System Product Portfolio Table 130. Cherry Biotech Recent Development Table 131. Ananda Devices Company Information Table 132. Ananda Devices Business Overview Table 133. Ananda Devices Microphysiological System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Ananda Devices Microphysiological System Product Portfolio Table 135. Ananda Devices Recent Development Table 136. Obatala Sciences Company Information Table 137. Obatala Sciences Business Overview Table 138. Obatala Sciences Microphysiological System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. Obatala Sciences Microphysiological System Product Portfolio Table 140. Obatala Sciences Recent Development Table 141. BiomimX Company Information Table 142. BiomimX Business Overview Table 143. BiomimX Microphysiological System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 144. BiomimX Microphysiological System Product Portfolio Table 145. BiomimX Recent Development Table 146. React4life Company Information Table 147. React4life Business Overview Table 148. React4life Microphysiological System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 149. React4life Microphysiological System Product Portfolio Table 150. React4life Recent Development Table 151. Aracari Bio Company Information Table 152. Aracari Bio Business Overview Table 153. Aracari Bio Microphysiological System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 154. Aracari Bio Microphysiological System Product Portfolio Table 155. Aracari Bio Recent Development Table 156. StemPharm Company Information Table 157. StemPharm Business Overview Table 158. StemPharm Microphysiological System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 159. StemPharm Microphysiological System Product Portfolio Table 160. StemPharm Recent Development Table 161. SynVivo Company Information Table 162. SynVivo Business Overview Table 163. SynVivo Microphysiological System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 164. SynVivo Microphysiological System Product Portfolio Table 165. SynVivo Recent Development Table 166. North America Microphysiological System Revenue by Type (2021-2026) & (US$ Million) Table 167. North America Microphysiological System Revenue by Type (2027-2032) & (US$ Million) Table 168. North America Microphysiological System Revenue by Application (2021-2026) & (US$ Million) Table 169. North America Microphysiological System Revenue by Application (2027-2032) & (US$ Million) Table 170. North America Microphysiological System Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 171. North America Microphysiological System Revenue by Country (2021-2026) & (US$ Million) Table 172. North America Microphysiological System Revenue by Country (US$ Million) & (2027-2032) Table 173. Europe Microphysiological System Revenue by Type (2021-2026) & (US$ Million) Table 174. Europe Microphysiological System Revenue by Type (2027-2032) & (US$ Million) Table 175. Europe Microphysiological System Revenue by Application (2021-2026) & (US$ Million) Table 176. Europe Microphysiological System Revenue by Application (2027-2032) & (US$ Million) Table 177. Europe Microphysiological System Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 178. Europe Microphysiological System Revenue by Country (2021-2026) & (US$ Million) Table 179. Europe Microphysiological System Revenue by Country (US$ Million) & (2027-2032) Table 180. China Microphysiological System Revenue by Type (2021-2026) & (US$ Million) Table 181. China Microphysiological System Revenue by Type (2027-2032) & (US$ Million) Table 182. China Microphysiological System Revenue by Application (2021-2026) & (US$ Million) Table 183. China Microphysiological System Revenue by Application (2027-2032) & (US$ Million) Table 184. Asia Microphysiological System Revenue by Type (2021-2026) & (US$ Million) Table 185. Asia Microphysiological System Revenue by Type (2027-2032) & (US$ Million) Table 186. Asia Microphysiological System Revenue by Application (2021-2026) & (US$ Million) Table 187. Asia Microphysiological System Revenue by Application (2027-2032) & (US$ Million) Table 188. Asia Microphysiological System Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 189. Asia Microphysiological System Revenue by Region (US$ Million) & (2021-2026) Table 190. Asia Microphysiological System Revenue by Region (US$ Million) & (2027-2032) Table 191. SAMEA Microphysiological System Revenue by Type (2021-2026) & (US$ Million) Table 192. SAMEA Microphysiological System Revenue by Type (2027-2032) & (US$ Million) Table 193. SAMEA Microphysiological System Revenue by Application (2021-2026) & (US$ Million) Table 194. SAMEA Microphysiological System Revenue by Application (2027-2032) & (US$ Million) Table 195. SAMEA Microphysiological System Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 196. SAMEA Microphysiological System Revenue by Country (2021-2026) & (US$ Million) Table 197. SAMEA Microphysiological System Revenue by Country (US$ Million) & (2027-2032) Table 198. Research Programs/Design for This Report Table 199. Authors List of This Report Table 200. Secondary Sources Table 201. Primary Sources List of Figures Figure 1. Microphysiological System Image Figure 2. Global Microphysiological System Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Microphysiological System Market Size Share 2021 VS 2025 VS 2032 Figure 4. Human Organ and Tissue Models Image Figure 5. Disease Models Image Figure 6. Non-Human Species Models Image Figure 7. Global Microphysiological System Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Microphysiological System Market Size Share 2021 VS 2025 VS 2032 Figure 9. Pharmaceutical & Biotechnology Companies Image Figure 10. Academic & Research Institutes Image Figure 11. Others Image Figure 12. Global Microphysiological System Market Size (US$ Million) & (2021-2032) Figure 13. Global Microphysiological System Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Microphysiological System Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Microphysiological System Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Microphysiological System Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Microphysiological System Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Microphysiological System Revenue Market Share by Type (2021-2032) Figure 20. Global Microphysiological System Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Microphysiological System Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Microphysiological System Revenue Market Share by Application (2021-2032) Figure 23. North America Microphysiological System Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Microphysiological System Revenue Share by Type (2021-2032) Figure 25. North America Microphysiological System Revenue Share by Application (2021-2032) Figure 26. North America Microphysiological System Revenue Share by Country (2021-2032) Figure 27. United States Microphysiological System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Microphysiological System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Microphysiological System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Microphysiological System Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Microphysiological System Revenue Share by Type (2021-2032) Figure 32. Europe Microphysiological System Revenue Share by Application (2021-2032) Figure 33. Europe Microphysiological System Revenue Share by Country (2021-2032) Figure 34. Germany Microphysiological System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Microphysiological System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Microphysiological System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Microphysiological System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Microphysiological System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Microphysiological System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Microphysiological System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Microphysiological System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Microphysiological System Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Microphysiological System Revenue Share by Type (2021-2032) Figure 44. China Microphysiological System Revenue Share by Application (2021-2032) Figure 45. Asia Microphysiological System Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Microphysiological System Revenue Share by Type (2021-2032) Figure 47. Asia Microphysiological System Revenue Share by Application (2021-2032) Figure 48. Asia Microphysiological System Revenue Share by Region (2021-2032) Figure 49. Japan Microphysiological System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Microphysiological System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Microphysiological System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Microphysiological System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Microphysiological System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Microphysiological System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Microphysiological System Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Microphysiological System Revenue Share by Type (2021-2032) Figure 57. SAMEA Microphysiological System Revenue Share by Application (2021-2032) Figure 58. SAMEA Microphysiological System Revenue Share by Country (2021-2032) Figure 59. Brazil Microphysiological System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Microphysiological System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Microphysiological System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Microphysiological System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Microphysiological System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Microphysiological System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Microphysiological System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Microphysiological System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Microphysiological System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Microphysiological System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Microphysiological System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Human Organ and Tissue Models
  • Disease Models
  • Non-Human Species Models
Applications
  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Others
Companies covered
  • Emulate
  • Mimetas
  • TissUse
  • InSphero
  • Hesperos
  • CN Bio
  • TNO
  • 28bio
  • Beijing Daxiang Biotech
  • Newcells Biotech
  • Nortis (Quris-Al)
  • Valo Health (TARA Biosystems)
  • Altis Biosystems
  • Draper Laboratory
  • Netri
  • Bi/ond
  • ImmuONE
  • AlveoliX
  • Cherry Biotech
  • Ananda Devices
  • Obatala Sciences
  • BiomimX
  • React4life
  • Aracari Bio
  • StemPharm
  • SynVivo

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Microphysiological System Market by Type
  3. 1.2.1 Global Microphysiological System Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Human Organ and Tissue Models
  5. 1.2.3 Disease Models
  6. 1.2.4 Non-Human Species Models
  7. 1.3 Microphysiological System Market by Application
  8. 1.3.1 Global Microphysiological System Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Pharmaceutical & Biotechnology Companies
  10. 1.3.3 Academic & Research Institutes
  11. 1.3.4 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Microphysiological System Market Dynamics
  1. 2.1 Microphysiological System Industry Trends
  2. 2.2 Microphysiological System Industry Drivers
  3. 2.3 Microphysiological System Industry Opportunities and Challenges
  4. 2.4 Microphysiological System Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Microphysiological System Market Perspective (2021-2032)
  2. 3.2 Global Microphysiological System Growth Trends by Region
  3. 3.2.1 Global Microphysiological System Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Microphysiological System Market Size by Region (2021-2026)
  5. 3.2.3 Global Microphysiological System Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Microphysiological System Revenue by Players
  2. 4.1.1 Global Microphysiological System Revenue by Players (2021-2026)
  3. 4.1.2 Global Microphysiological System Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Microphysiological System Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Microphysiological System Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Microphysiological System Key Players Headquarters & Area Served
  7. 4.4 Global Microphysiological System Players, Product Type & Application
  8. 4.5 Global Microphysiological System Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Microphysiological System Market CR5 and HHI
  11. 4.6.3 2025 Microphysiological System Tier 1, Tier 2, and Tier 3
5 Microphysiological System Market Size by Type
  1. 5.1 Global Microphysiological System Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Microphysiological System Revenue by Type (2021-2032)
  3. 5.3 Global Microphysiological System Revenue Market Share by Type (2021-2032)
6 Microphysiological System Market Size by Application
  1. 6.1 Global Microphysiological System Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Microphysiological System Revenue by Application (2021-2032)
  3. 6.3 Global Microphysiological System Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Emulate
  2. 7.1.1 Emulate Company Information
  3. 7.1.2 Emulate Business Overview
  4. 7.1.3 Emulate Microphysiological System Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Emulate Microphysiological System Product Portfolio
  6. 7.1.5 Emulate Recent Developments
  7. 7.2 Mimetas
  8. 7.2.1 Mimetas Company Information
  9. 7.2.2 Mimetas Business Overview
  10. 7.2.3 Mimetas Microphysiological System Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Mimetas Microphysiological System Product Portfolio
  12. 7.2.5 Mimetas Recent Developments
  13. 7.3 TissUse
  14. 7.3.1 TissUse Company Information
  15. 7.3.2 TissUse Business Overview
  16. 7.3.3 TissUse Microphysiological System Revenue and Gross Margin (2021-2026)
  17. 7.3.4 TissUse Microphysiological System Product Portfolio
  18. 7.3.5 TissUse Recent Developments
  19. 7.4 InSphero
  20. 7.4.1 InSphero Company Information
  21. 7.4.2 InSphero Business Overview
  22. 7.4.3 InSphero Microphysiological System Revenue and Gross Margin (2021-2026)
  23. 7.4.4 InSphero Microphysiological System Product Portfolio
  24. 7.4.5 InSphero Recent Developments
  25. 7.5 Hesperos
  26. 7.5.1 Hesperos Company Information
  27. 7.5.2 Hesperos Business Overview
  28. 7.5.3 Hesperos Microphysiological System Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Hesperos Microphysiological System Product Portfolio
  30. 7.5.5 Hesperos Recent Developments
  31. 7.6 CN Bio
  32. 7.6.1 CN Bio Company Information
  33. 7.6.2 CN Bio Business Overview
  34. 7.6.3 CN Bio Microphysiological System Revenue and Gross Margin (2021-2026)
  35. 7.6.4 CN Bio Microphysiological System Product Portfolio
  36. 7.6.5 CN Bio Recent Developments
  37. 7.7 TNO
  38. 7.7.1 TNO Company Information
  39. 7.7.2 TNO Business Overview
  40. 7.7.3 TNO Microphysiological System Revenue and Gross Margin (2021-2026)
  41. 7.7.4 TNO Microphysiological System Product Portfolio
  42. 7.7.5 TNO Recent Developments
  43. 7.8 28bio
  44. 7.8.1 28bio Company Information
  45. 7.8.2 28bio Business Overview
  46. 7.8.3 28bio Microphysiological System Revenue and Gross Margin (2021-2026)
  47. 7.8.4 28bio Microphysiological System Product Portfolio
  48. 7.8.5 28bio Recent Developments
  49. 7.9 Beijing Daxiang Biotech
  50. 7.9.1 Beijing Daxiang Biotech Company Information
  51. 7.9.2 Beijing Daxiang Biotech Business Overview
  52. 7.9.3 Beijing Daxiang Biotech Microphysiological System Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Beijing Daxiang Biotech Microphysiological System Product Portfolio
  54. 7.9.5 Beijing Daxiang Biotech Recent Developments
  55. 7.10 Newcells Biotech
  56. 7.10.1 Newcells Biotech Company Information
  57. 7.10.2 Newcells Biotech Business Overview
  58. 7.10.3 Newcells Biotech Microphysiological System Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Newcells Biotech Microphysiological System Product Portfolio
  60. 7.10.5 Newcells Biotech Recent Developments
  61. 7.11 Nortis (Quris-Al)
  62. 7.11.1 Nortis (Quris-Al) Company Information
  63. 7.11.2 Nortis (Quris-Al) Business Overview
  64. 7.11.3 Nortis (Quris-Al) Microphysiological System Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Nortis (Quris-Al) Microphysiological System Product Portfolio
  66. 7.11.5 Nortis (Quris-Al) Recent Developments
  67. 7.12 Valo Health (TARA Biosystems)
  68. 7.12.1 Valo Health (TARA Biosystems) Company Information
  69. 7.12.2 Valo Health (TARA Biosystems) Business Overview
  70. 7.12.3 Valo Health (TARA Biosystems) Microphysiological System Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Valo Health (TARA Biosystems) Microphysiological System Product Portfolio
  72. 7.12.5 Valo Health (TARA Biosystems) Recent Developments
  73. 7.13 Altis Biosystems
  74. 7.13.1 Altis Biosystems Company Information
  75. 7.13.2 Altis Biosystems Business Overview
  76. 7.13.3 Altis Biosystems Microphysiological System Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Altis Biosystems Microphysiological System Product Portfolio
  78. 7.13.5 Altis Biosystems Recent Developments
  79. 7.14 Draper Laboratory
  80. 7.14.1 Draper Laboratory Company Information
  81. 7.14.2 Draper Laboratory Business Overview
  82. 7.14.3 Draper Laboratory Microphysiological System Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Draper Laboratory Microphysiological System Product Portfolio
  84. 7.14.5 Draper Laboratory Recent Developments
  85. 7.15 Netri
  86. 7.15.1 Netri Company Information
  87. 7.15.2 Netri Business Overview
  88. 7.15.3 Netri Microphysiological System Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Netri Microphysiological System Product Portfolio
  90. 7.15.5 Netri Recent Developments
  91. 7.16 Bi/ond
  92. 7.16.1 Bi/ond Company Information
  93. 7.16.2 Bi/ond Business Overview
  94. 7.16.3 Bi/ond Microphysiological System Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Bi/ond Microphysiological System Product Portfolio
  96. 7.16.5 Bi/ond Recent Developments
  97. 7.17 ImmuONE
  98. 7.17.1 ImmuONE Company Information
  99. 7.17.2 ImmuONE Business Overview
  100. 7.17.3 ImmuONE Microphysiological System Revenue and Gross Margin (2021-2026)
  101. 7.17.4 ImmuONE Microphysiological System Product Portfolio
  102. 7.17.5 ImmuONE Recent Developments
  103. 7.18 AlveoliX
  104. 7.18.1 AlveoliX Company Information
  105. 7.18.2 AlveoliX Business Overview
  106. 7.18.3 AlveoliX Microphysiological System Revenue and Gross Margin (2021-2026)
  107. 7.18.4 AlveoliX Microphysiological System Product Portfolio
  108. 7.18.5 AlveoliX Recent Developments
  109. 7.19 Cherry Biotech
  110. 7.19.1 Cherry Biotech Company Information
  111. 7.19.2 Cherry Biotech Business Overview
  112. 7.19.3 Cherry Biotech Microphysiological System Revenue and Gross Margin (2021-2026)
  113. 7.19.4 Cherry Biotech Microphysiological System Product Portfolio
  114. 7.19.5 Cherry Biotech Recent Developments
  115. 7.20 Ananda Devices
  116. 7.20.1 Ananda Devices Company Information
  117. 7.20.2 Ananda Devices Business Overview
  118. 7.20.3 Ananda Devices Microphysiological System Revenue and Gross Margin (2021-2026)
  119. 7.20.4 Ananda Devices Microphysiological System Product Portfolio
  120. 7.20.5 Ananda Devices Recent Developments
  121. 7.21 Obatala Sciences
  122. 7.21.1 Obatala Sciences Company Information
  123. 7.21.2 Obatala Sciences Business Overview
  124. 7.21.3 Obatala Sciences Microphysiological System Revenue and Gross Margin (2021-2026)
  125. 7.21.4 Obatala Sciences Microphysiological System Product Portfolio
  126. 7.21.5 Obatala Sciences Recent Developments
  127. 7.22 BiomimX
  128. 7.22.1 BiomimX Company Information
  129. 7.22.2 BiomimX Business Overview
  130. 7.22.3 BiomimX Microphysiological System Revenue and Gross Margin (2021-2026)
  131. 7.22.4 BiomimX Microphysiological System Product Portfolio
  132. 7.22.5 BiomimX Recent Developments
  133. 7.23 React4life
  134. 7.23.1 React4life Company Information
  135. 7.23.2 React4life Business Overview
  136. 7.23.3 React4life Microphysiological System Revenue and Gross Margin (2021-2026)
  137. 7.23.4 React4life Microphysiological System Product Portfolio
  138. 7.23.5 React4life Recent Developments
  139. 7.24 Aracari Bio
  140. 7.24.1 Aracari Bio Company Information
  141. 7.24.2 Aracari Bio Business Overview
  142. 7.24.3 Aracari Bio Microphysiological System Revenue and Gross Margin (2021-2026)
  143. 7.24.4 Aracari Bio Microphysiological System Product Portfolio
  144. 7.24.5 Aracari Bio Recent Developments
  145. 7.25 StemPharm
  146. 7.25.1 StemPharm Company Information
  147. 7.25.2 StemPharm Business Overview
  148. 7.25.3 StemPharm Microphysiological System Revenue and Gross Margin (2021-2026)
  149. 7.25.4 StemPharm Microphysiological System Product Portfolio
  150. 7.25.5 StemPharm Recent Developments
  151. 7.26 SynVivo
  152. 7.26.1 SynVivo Company Information
  153. 7.26.2 SynVivo Business Overview
  154. 7.26.3 SynVivo Microphysiological System Revenue and Gross Margin (2021-2026)
  155. 7.26.4 SynVivo Microphysiological System Product Portfolio
  156. 7.26.5 SynVivo Recent Developments
8 North America
  1. 8.1 North America Microphysiological System Revenue (2021-2032)
  2. 8.2 North America Microphysiological System Revenue by Type (2021-2032)
  3. 8.2.1 North America Microphysiological System Revenue by Type (2021-2026)
  4. 8.2.2 North America Microphysiological System Revenue by Type (2027-2032)
  5. 8.3 North America Microphysiological System Revenue Share by Type (2021-2032)
  6. 8.4 North America Microphysiological System Revenue by Application (2021-2032)
  7. 8.4.1 North America Microphysiological System Revenue by Application (2021-2026)
  8. 8.4.2 North America Microphysiological System Revenue by Application (2027-2032)
  9. 8.5 North America Microphysiological System Revenue Share by Application (2021-2032)
  10. 8.6 North America Microphysiological System Revenue by Country
  11. 8.6.1 North America Microphysiological System Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Microphysiological System Revenue by Country (2021-2026)
  13. 8.6.3 North America Microphysiological System Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Microphysiological System Revenue (2021-2032)
  2. 9.2 Europe Microphysiological System Revenue by Type (2021-2032)
  3. 9.2.1 Europe Microphysiological System Revenue by Type (2021-2026)
  4. 9.2.2 Europe Microphysiological System Revenue by Type (2027-2032)
  5. 9.3 Europe Microphysiological System Revenue Share by Type (2021-2032)
  6. 9.4 Europe Microphysiological System Revenue by Application (2021-2032)
  7. 9.4.1 Europe Microphysiological System Revenue by Application (2021-2026)
  8. 9.4.2 Europe Microphysiological System Revenue by Application (2027-2032)
  9. 9.5 Europe Microphysiological System Revenue Share by Application (2021-2032)
  10. 9.6 Europe Microphysiological System Revenue by Country
  11. 9.6.1 Europe Microphysiological System Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Microphysiological System Revenue by Country (2021-2026)
  13. 9.6.3 Europe Microphysiological System Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Microphysiological System Revenue (2021-2032)
  2. 10.2 China Microphysiological System Revenue by Type (2021-2032)
  3. 10.2.1 China Microphysiological System Revenue by Type (2021-2026)
  4. 10.2.2 China Microphysiological System Revenue by Type (2027-2032)
  5. 10.3 China Microphysiological System Revenue Share by Type (2021-2032)
  6. 10.4 China Microphysiological System Revenue by Application (2021-2032)
  7. 10.4.1 China Microphysiological System Revenue by Application (2021-2026)
  8. 10.4.2 China Microphysiological System Revenue by Application (2027-2032)
  9. 10.5 China Microphysiological System Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Microphysiological System Revenue (2021-2032)
  2. 11.2 Asia Microphysiological System Revenue by Type (2021-2032)
  3. 11.2.1 Asia Microphysiological System Revenue by Type (2021-2026)
  4. 11.2.2 Asia Microphysiological System Revenue by Type (2027-2032)
  5. 11.3 Asia Microphysiological System Revenue Share by Type (2021-2032)
  6. 11.4 Asia Microphysiological System Revenue by Application (2021-2032)
  7. 11.4.1 Asia Microphysiological System Revenue by Application (2021-2026)
  8. 11.4.2 Asia Microphysiological System Revenue by Application (2027-2032)
  9. 11.5 Asia Microphysiological System Revenue Share by Application (2021-2032)
  10. 11.6 Asia Microphysiological System Revenue by Country
  11. 11.6.1 Asia Microphysiological System Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Microphysiological System Revenue by Country (2021-2026)
  13. 11.6.3 Asia Microphysiological System Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Microphysiological System Revenue (2021-2032)
  2. 12.2 SAMEA Microphysiological System Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Microphysiological System Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Microphysiological System Revenue by Type (2027-2032)
  5. 12.3 SAMEA Microphysiological System Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Microphysiological System Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Microphysiological System Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Microphysiological System Revenue by Application (2027-2032)
  9. 12.5 SAMEA Microphysiological System Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Microphysiological System Revenue by Country
  11. 12.6.1 SAMEA Microphysiological System Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Microphysiological System Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Microphysiological System Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst